54 The epidermal growth factor receptor tyrosine kinase inhibitor, eriotinib (Tarceva TM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: interim results of a phase II trial
Open Access
- 30 September 2003
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 1 (5) , S21
- https://doi.org/10.1016/s1359-6349(03)90089-9
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: